ArticleAmerican journal of cardiovascular disease2021
Oxidative status and antioxidant enzyme levels in deep venous thrombosis patients.
Article in American journal of cardiovascular disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 12 citations in OpenAlex.
- Metabolic pathways in deep vein thrombosis: a new frontier for therapeutic intervention.Blood · 2025Review
- Rpl13a snoRNAs-regulated NADPH oxidase 1-dependent ROS generation: A novel RBC pathway mediating complement C3a deposition and triggering thrombosis in aging and venous blood clotting disorders.Free radical biology & medicine · 2025Article
- Red blood cell Rpl13a small noncoding nucleolar RNAs guides 2'-O-methylation on peroxidasin messenger RNA promoting venous thrombosis in aging.Journal of thrombosis and haemostasis : JTH · 2025Article
- Evaluation of expression of genes associated with post-thrombotic syndrome.Jornal vascular brasileiro · 2025Article
- Oxidative Status, Iron Plasma Levels in Venous Thrombosis Patients.Antioxidants (Basel, Switzerland) · 2024Article
- Acute venous thromboembolism plasma and red blood cell metabolomic profiling reveals potential new early diagnostic biomarkers: observational clinical study.Journal of translational medicine · 2024Observational
- Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function.Open life sciences · 2023Article
- Paracetamol in the home treatment of early COVID-19 symptoms: A possible foe rather than a friend for elderly patients?Journal of medical virology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep vein thrombosis (DVT), a subset of venous thromboembolism (VTE), is a major preventable cause of morbidity and mortality worldwide. We aim to investigate changes in oxidative injury markers and the levels of antioxidant parameters in DVT patients. 50 DVT patients who were admitted to the cardiovascular surgery clinic with acute (<2 weeks) or chronic (≥4 weeks) DVT and 100 healthy individuals were included. As oxidative injury marker malondialdehyde and the antioxidant parameters including reduced glutathione, glutathione peroxidase, catalase, and superoxide dismutase were analysed in the collected peripheral blood samples. Demographic characteristics of the acute and chronic DVT patients were similar (P>0.05). In all DVT patients having thrombosis in the distal and proximal leg veins the mean malondialdehyde and glutathione peroxidase activity were significantly increased, but superoxide dismutase activity significantly decreased, compared to the healthy controls (P<0.05). No difference was observed between distal and proximal DVT patient groups. The increased levels of malondialdehyde in our study is considered to result from the significant decrease in the antioxidant enzyme activity of superoxide dismutase. Furthermore, we are of the opinion that the increased levels of glutathione peroxidase enzyme activity observed in all patients could not compensate the reduction in the superoxide dismutase activity, thereby being insufficient in preventing the increase in the malondialdehyde levels.
Indexed as
Identifiers
33815933PMC8012287W3149635675What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.